Description:
Abexinostat, also known as PCI-24781 or CRA-024781, is a novel, broad-spectrum hydroxamic acid-based inhibitor of histone deacetylase (HDAC) with potential antineoplastic activity. Abexinostat inhibits several isoforms of HDAC, resulting in an accumulation of highly acetylated histones, followed by the induction of chromatin remodeling.
- Molecular Weight:397.431
- Purity:98%
Molecular Formula:
C21H23N3O5
Canonical SMILES:
CN(C)CC1=C(OC2=CC=CC=C21)C(=O)NCCOC3=CC=C(C=C3)C(=O)NO
InChI:
InChI=1S/C21H23N3O5/c1-24(2)13-17-16-5-3-4-6-18(16)29-19(17)21(26)22-11-12-28-15-9-7-14(8-10-15)20(25)23-27/h3-10,27H,11-13H2,1-2H3,(H,22,26)(H,23,25)
InChIKey:
MAUCONCHVWBMHK-UHFFFAOYSA-N
Appearance:
white solid powder
Synonyms:
CRA-024781; CRA 024781; CRA024781; PCI-24781; PCI24781; PCI 24781 Más detalles se encuentran
aquí